Activation and activities of the p53 tumour suppressor protein

Abstract

The p53 tumour suppressor protein inhibits malignant progression by mediating cell cycle arrest, apoptosis or repair following cellular stress. One of the major regulators of p53 function is the MDM2 protein, and multiple forms of cellular stress activate p53 by inhibiting the MDM2-mediated degradation of p53. Mutations in p53, or disruption of the pathways that allow activation of p53, seem to be a general feature of all cancers. Here we review recent advances in our understanding of the pathways that regulate p53 and the pathways that are induced by p53, as well as their implications for cancer therapy.

References 212

1. 1.

   Abrahamson J. L., Lee J. M., Bernstein A. Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor. Mol Cell Biol. 1995;15(12):6953-6960.

   Not in our library10.1128/mcb.15.12.6953

2. 2.

   Agarwal M. L., Agarwal A., Taylor W. R., Stark G. R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A. 1995;92(18):8493-8497.

   Not in our library10.1073/pnas.92.18.8493

3. 3.

   Albrechtsen N., Dornreiter I., Grosse F., Kim E., Wiesmüller L., Deppert W. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene. 1999;18(53):7706-7717.

   Not in our library10.1038/sj.onc.1202952

4. 4.

   Almog N., Rotter V. Involvement of p53 in cell differentiation and development. Biochim Biophys Acta. 1997;1333(1):F1-27.

   Not in our library10.1016/s0304-419x(97)00012-7

5. 5.

   An W. G., Kanekal M., Simon M. C., Maltepe E., Blagosklonny M. V., Neckers L. M. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature. 1998;392(6674):405-408.

   Not in our library10.1038/32925

6. 6.

   Arriola E. L., Lopez A. R., Chresta C. M. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. Oncogene. 1999;18(4):1081-1091.

   Not in our library10.1038/sj.onc.1202391

7. 7.

   Ashcroft M., Kubbutat M. H., Vousden K. H. Regulation of p53 function and stability by phosphorylation. Mol Cell Biol. 1999;19(3):1751-1758.

   Not in our library10.1128/mcb.19.3.1751

8. 8.

   Ashcroft M., Taya Y., Vousden K. H. Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol. 2000;20(9):3224-3233.

   Not in our library10.1128/mcb.20.9.3224-3233.2000

9. 9.

   Ashcroft M., Vousden K. H. Regulation of p53 stability. Oncogene. 1999;18(53):7637-7643.

   Not in our library10.1038/sj.onc.1203012

10. 10.

    Ashkenazi A., Dixit V. M. Death receptors: signaling and modulation. Science. 1998;281(5381):1305-1308.

    Not in our library10.1126/science.281.5381.1305

11. 11.

    Atencio I. A., Ramachandra M., Shabram P., Demers G. W. Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ. 2000;11(5):247-253.

    Not in our library

12. 12.

    Bachelder R. E., Ribick M. J., Marchetti A., Falcioni R., Soddu S., Davis K. R., Mercurio A. M. p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J Cell Biol. 1999;147(5):1063-1072.

    Not in our library10.1083/jcb.147.5.1063

13. 13.

    Barak Y., Juven T., Haffner R., Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J. 1993;12(2):461-468.

    Not in our library10.1002/j.1460-2075.1993.tb05678.x

14. 14.

    Bates S., Phillips A. C., Clark P. A., Stott F., Peters G., Ludwig R. L., Vousden K. H. p14ARF links the tumour suppressors RB and p53. Nature. 1998;395(6698):124-125.

    Not in our library10.1038/25867

15. 15.

    Bates S., Ryan K. M., Phillips A. C., Vousden K. H. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene. 1998;17(13):1691-1703.

    Not in our library10.1038/sj.onc.1202104

16. 16.

    Bell D. W., Varley J. M., Szydlo T. E., Kang D. H., Wahrer D. C., Shannon K. E., Lubratovich M., Verselis S. J., Isselbacher K. J., Fraumeni J. F. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 1999;286(5449):2528-2531.

    Not in our library10.1126/science.286.5449.2528

17. 17.

    Bennett M., Macdonald K., Chan S. W., Luzio J. P., Simari R., Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 1998;282(5387):290-293.

    Not in our library10.1126/science.282.5387.290

18. 18.

    Blander G., Zalle N., Leal J. F., Bar-Or R. L., Yu C. E., Oren M. The Werner syndrome protein contributes to induction of p53 by DNA damage. FASEB J. 2000;14(14):2138-2140.

    Not in our library10.1096/fj.00-0171fje

19. 19.

    Blattner C., Tobiasch E., Litfen M., Rahmsdorf H. J., Herrlich P. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene. 1999;18(9):1723-1732.

    Not in our library10.1038/sj.onc.1202480

20. 20.

    Bossy-Wetzel E., Green D. R. Apoptosis: checkpoint at the mitochondrial frontier. Mutat Res. 1999;434(3):243-251.

    Not in our library10.1016/s0921-8777(99)00032-4

21. 21.

    Bouvet M., Ellis L. M., Nishizaki M., Fujiwara T., Liu W., Bucana C. D., Fang B., Lee J. J., Roth J. A. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 1998;58(11):2288-2292.

    Not in our library

22. 22.

    Boyd M. T., Vlatkovic N., Haines D. S. A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2. J Biol Chem. 2000;275(41):31883-31890.

    Not in our library10.1074/jbc.m004252200

23. 23.

    Boyd S. D., Tsai K. Y., Jacks T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol. 2000;2(9):563-568.

    Not in our library10.1038/35023500

24. 24.

    Brugarolas J., Chandrasekaran C., Gordon J. I., Beach D., Jacks T., Hannon G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 1995;377(6549):552-557.

    Not in our library10.1038/377552a0

25. 25.

    Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B. R., Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 1995;377(6550):646-649.

    Not in our library10.1038/377646a0

26. 26.

    Butz K., Denk C., Ullmann A., Scheffner M., Hoppe-Seyler F. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc Natl Acad Sci U S A. 2000;97(12):6693-6697.

    Not in our library10.1073/pnas.110538897

27. 27.

    Bálint E., Bates S., Vousden K. H. Mdm2 binds p73 alpha without targeting degradation. Oncogene. 1999;18(27):3923-3929.

    Not in our library10.1038/sj.onc.1202781

28. 28.

    Böttger A., Böttger V., Sparks A., Liu W. L., Howard S. F., Lane D. P. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol. 1997;7(11):860-869.

    Not in our library10.1016/s0960-9822(06)00374-5

29. 29.

    Canman C. E., Gilmer T. M., Coutts S. B., Kastan M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 1995;9(5):600-611.

    Not in our library10.1101/gad.9.5.600

30. 30.

    Chan T. A., Hermeking H., Lengauer C., Kinzler K. W., Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature. 1999;401(6753):616-620.

    Not in our library10.1038/44188

31. 31.

    Chao C., Saito S., Kang J., Anderson C. W., Appella E., Xu Y. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 2000;19(18):4967-4975.

    Not in our library10.1093/emboj/19.18.4967

32. 32.

    Chehab N. H., Malikzay A., Appel M., Halazonetis T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 2000;14(3):278-288.

    Not in our library

33. 33.

    Chen L., Lu W., Agrawal S., Zhou W., Zhang R., Chen J. Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression. Mol Med. 1999;5(1):21-34.

    Not in our library

34. 34.

    Chen X., Ko L. J., Jayaraman L., Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 1996;10(19):2438-2451.

    Not in our library10.1101/gad.10.19.2438

35. 35.

    Crook T., Marston N. J., Sara E. A., Vousden K. H. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell. 1994;79(5):817-827.

    Not in our library10.1016/0092-8674(94)90071-x

36. 36.

    Crook T., Wrede D., Tidy J. A., Mason W. P., Evans D. J., Vousden K. H. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet. 1992;339(8801):1070-1073.

    Not in our library10.1016/0140-6736(92)90662-m

37. 37.

    Damalas A., Ben-Ze'ev A., Simcha I., Shtutman M., Leal J. F., Zhurinsky J., Geiger B., Oren M. Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 1999;18(11):3054-3063.

    Not in our library10.1093/emboj/18.11.3054

38. 38.

    Dameron K. M., Volpert O. V., Tainsky M. A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994;265(5178):1582-1584.

    Not in our library10.1126/science.7521539

39. 39.

    Dobbelstein M., Wienzek S., König C., Roth J. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene. 1999;18(12):2101-2106.

    Not in our library10.1038/sj.onc.1202512

40. 40.

    Donehower L. A. The p53-deficient mouse: a model for basic and applied cancer studies. Semin Cancer Biol. 1996;7(5):269-278.

    Not in our library10.1006/scbi.1996.0035

Cited by papers we hold 2

• Tumor Suppressor p53 Alters Host Cell Metabolism to Limit Chlamydia trachomatis Infection · 2014
  Not checked
• P53 abnormalities and outcomes in colorectal cancer: a systematic review · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.